BibTex RIS Cite

A case of zellweger syndrome accompanied by hypertrophic cardiomyopathy

Year 2016, Volume: 3 Issue: 5, 242 - 4, 15.05.2016

Abstract

Peroxisomal biogenesis disorders are a group of genetically and clinically heterogenous disorders which affect very-long chain fatty acid metabolism. Zellweger syndrome (ZS) is a rare, congenital disorder characterized by multisystem involvement including central nervous system, skeletal system, liver, kidney and eyes, due to absence of peroxisomes in the cells. Hypertrophic cardiomyopathy (HCM) is defined as septal or posterior wall thickness that is more than two standard deviations above the mean normal thickness measured by echocardiography. Here we present a newborn with Zellweger syndrome and hypertrophic cardiomyopathy.

References

  • Wanders, R. J. A. Metabolic and molecular basis of peroxisomal disorders: a review. Am. J. Med. Genet 2004; 126: 355-75.
  • Gould SJ, Raymond GV, Valle D. The peroxisome biogenesis disorders. In: Scriver CR, Beaudet AL, Valle D, Sly WS (eds) The metabolic & molecular bases of inherited disease. New York: McGraw-Hill, 2001.p. 3181–217.
  • Ng PC. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia. Arch Dis Child 1993; 68: 330-36.
  • Ben-Shacher G, Moller JH, Castaneda-Zuniga W, Edwards JE. Signs of membranous subaortic stenosis appearing after correction of persistent common atrioventricular canal. Am J Cardiol 1981; 48: 340-4.
  • Grayer J. Recognition of Zellweger syndrome in infancy. Adv Neonatal Care. 2005; 5: 5-13.
  • Kelley RI, Datta NS, Dobyns WB, Hajra AK, Moser AB, Noetzel MJ, et al. Neonatal adrenoleukodystrophy: New cases, biochemical studies, and differentiation from Zellweger and related peroxisomal polydystrophy sydnromes. Am J Med Genet 1986; 23: 869-901.
  • Badertscher A, Bauersfeld U, Arbenz U, Baumgartner MR, Schinzel A, Balmer C. Cardiomyopathy in newborns and infants: a broad spectrum of aetiologies and poor prognosis. Acta Paediatr 2008; 97: 1523-8.

A case of Zellweger syndrome accompanied by hypertrophic cardiomyopathy

Year 2016, Volume: 3 Issue: 5, 242 - 4, 15.05.2016

Abstract

References

  • Wanders, R. J. A. Metabolic and molecular basis of peroxisomal disorders: a review. Am. J. Med. Genet 2004; 126: 355-75.
  • Gould SJ, Raymond GV, Valle D. The peroxisome biogenesis disorders. In: Scriver CR, Beaudet AL, Valle D, Sly WS (eds) The metabolic & molecular bases of inherited disease. New York: McGraw-Hill, 2001.p. 3181–217.
  • Ng PC. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia. Arch Dis Child 1993; 68: 330-36.
  • Ben-Shacher G, Moller JH, Castaneda-Zuniga W, Edwards JE. Signs of membranous subaortic stenosis appearing after correction of persistent common atrioventricular canal. Am J Cardiol 1981; 48: 340-4.
  • Grayer J. Recognition of Zellweger syndrome in infancy. Adv Neonatal Care. 2005; 5: 5-13.
  • Kelley RI, Datta NS, Dobyns WB, Hajra AK, Moser AB, Noetzel MJ, et al. Neonatal adrenoleukodystrophy: New cases, biochemical studies, and differentiation from Zellweger and related peroxisomal polydystrophy sydnromes. Am J Med Genet 1986; 23: 869-901.
  • Badertscher A, Bauersfeld U, Arbenz U, Baumgartner MR, Schinzel A, Balmer C. Cardiomyopathy in newborns and infants: a broad spectrum of aetiologies and poor prognosis. Acta Paediatr 2008; 97: 1523-8.
There are 7 citations in total.

Details

Primary Language English
Journal Section Case Reports
Authors

Yusuf Kale

Istemi Celik

Ferit Kulali This is me

Osman Yilmaz This is me

Ahmet Bas

Nihal Demirel

Publication Date May 15, 2016
Published in Issue Year 2016 Volume: 3 Issue: 5

Cite

APA Kale, Y., Celik, I., Kulali, F., Yilmaz, O., et al. (2016). A case of zellweger syndrome accompanied by hypertrophic cardiomyopathy. Medical Science and Discovery, 3(5), 242-4. https://doi.org/10.17546/msd.72829
AMA Kale Y, Celik I, Kulali F, Yilmaz O, Bas A, Demirel N. A case of zellweger syndrome accompanied by hypertrophic cardiomyopathy. Med Sci Discov. May 2016;3(5):242-4. doi:10.17546/msd.72829
Chicago Kale, Yusuf, Istemi Celik, Ferit Kulali, Osman Yilmaz, Ahmet Bas, and Nihal Demirel. “A Case of Zellweger Syndrome Accompanied by Hypertrophic Cardiomyopathy”. Medical Science and Discovery 3, no. 5 (May 2016): 242-4. https://doi.org/10.17546/msd.72829.
EndNote Kale Y, Celik I, Kulali F, Yilmaz O, Bas A, Demirel N (May 1, 2016) A case of zellweger syndrome accompanied by hypertrophic cardiomyopathy. Medical Science and Discovery 3 5 242–4.
IEEE Y. Kale, I. Celik, F. Kulali, O. Yilmaz, A. Bas, and N. Demirel, “A case of zellweger syndrome accompanied by hypertrophic cardiomyopathy”, Med Sci Discov, vol. 3, no. 5, pp. 242–4, 2016, doi: 10.17546/msd.72829.
ISNAD Kale, Yusuf et al. “A Case of Zellweger Syndrome Accompanied by Hypertrophic Cardiomyopathy”. Medical Science and Discovery 3/5 (May 2016), 242-4. https://doi.org/10.17546/msd.72829.
JAMA Kale Y, Celik I, Kulali F, Yilmaz O, Bas A, Demirel N. A case of zellweger syndrome accompanied by hypertrophic cardiomyopathy. Med Sci Discov. 2016;3:242–4.
MLA Kale, Yusuf et al. “A Case of Zellweger Syndrome Accompanied by Hypertrophic Cardiomyopathy”. Medical Science and Discovery, vol. 3, no. 5, 2016, pp. 242-4, doi:10.17546/msd.72829.
Vancouver Kale Y, Celik I, Kulali F, Yilmaz O, Bas A, Demirel N. A case of zellweger syndrome accompanied by hypertrophic cardiomyopathy. Med Sci Discov. 2016;3(5):242-4.